Antifungal susceptibility profiles and drug resistance mechanisms of clinical Candida duobushaemulonii isolates from China

Candida duobushaemulonii, type II Candida haemulonii complex, is closely related to Candida auris and capable of causing invasive and non-invasive infections in humans. Eleven strains of C. duobushaemulonii were collected from China Hospital Invasive Fungal Surveillance Net (CHIF-NET) and identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF), VITEK 2 Yeast Identification Card (YST), and internal transcribed spacer (ITS) sequencing. Whole genome sequencing of C. duobushaemulonii was done to determine their genotypes. Furthermore, C. duobushaemulonii strains were tested by Sensititre YeastOne™ and Clinical and Laboratory Institute (CLSI) broth microdilution panel for antifungal susceptibility. Three C. duobushaemulonii could not be identified by VITEK 2. All 11 isolates had high minimum inhibitory concentrations (MICs) to amphotericin B more than 2 μg/ml. One isolate showed a high MIC value of ≥64 μg/ml to 5-flucytosine. All isolates were wild type (WT) for triazoles and echinocandins. FUR1 variation may result in C. duobushaemulonii with high MIC to 5-flucytosine. Candida duobushaemulonii mainly infects patients with weakened immunity, and the amphotericin B resistance of these isolates might represent a challenge to clinical treatment.

[1]  R. Zancopé-Oliveira,et al.  The Threat Called Candida haemulonii Species Complex in Rio de Janeiro State, Brazil: Focus on Antifungal Resistance and Virulence Attributes , 2022, Journal of fungi.

[2]  G. Quindós,et al.  Candida duobushaemulonii: An Old But Unreported Pathogen , 2020, Journal of fungi.

[3]  Guanghua Huang,et al.  Candida auris: Epidemiology, biology, antifungal resistance, and virulence , 2020, PLoS pathogens.

[4]  Brendan R. Jackson,et al.  Understanding the Emergence of Multidrug-Resistant Candida: Using Whole-Genome Sequencing to Describe the Population Structure of Candida haemulonii Species Complex , 2020, Frontiers in Genetics.

[5]  A. L. Santos,et al.  Unmasking the amphotericin B resistance mechanisms in Candida haemulonii species complex. , 2020, ACS infectious diseases.

[6]  C. Cuomo,et al.  Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study , 2019, Journal of Clinical Microbiology.

[7]  C. Rodríguez-Cerdeira,et al.  Superficial candidosis by Candida duobushaemulonii: An emerging microorganism. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[8]  J. Flowers,et al.  Origins and geographic diversification of African rice (Oryza glaberrima) , 2018, bioRxiv.

[9]  Lori Rowe,et al.  Genome Sequence of the Amphotericin B-Resistant Candida duobushaemulonii Strain B09383 , 2018, Genome Announcements.

[10]  Juan C. Sánchez-DelBarrio,et al.  DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets. , 2017, Molecular biology and evolution.

[11]  M. Arendrup,et al.  Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment , 2017, The Journal of infectious diseases.

[12]  E. Berkow,et al.  Fluconazole resistance in Candida species: a current perspective , 2017, Infection and drug resistance.

[13]  Chieh-Shan Wu,et al.  Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68‐year‐old man: the first case report and literature review , 2016, Mycoses.

[14]  F. Kong,et al.  Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China , 2016, Journal of Clinical Microbiology.

[15]  F. Kong,et al.  Sequencer-Based Capillary Gel Electrophoresis (SCGE) Targeting the rDNA Internal Transcribed Spacer (ITS) Regions for Accurate Identification of Clinically Important Yeast Species , 2016, PloS one.

[16]  F. Rossi,et al.  Candida haemulonii Complex Species, Brazil, January 2010–March 2015 , 2016, Emerging infectious diseases.

[17]  A. Son,et al.  Portable lysis apparatus for rapid single‐step DNA extraction of Bacillus subtilis , 2016, Journal of applied microbiology.

[18]  D. Thompson,et al.  YMAP: a pipeline for visualization of copy number variation and loss of heterozygosity in eukaryotic pathogens , 2014, Genome Medicine.

[19]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[20]  F. Kong,et al.  Yeast Identification Algorithm Based on Use of the Vitek MS System Selectively Supplemented with Ribosomal DNA Sequencing: Proposal of a Reference Assay for Invasive Fungal Surveillance Programs in China , 2013, Journal of Clinical Microbiology.

[21]  M. Kostrzewa,et al.  Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts , 2012, Journal of Clinical Microbiology.

[22]  M. Ghannoum,et al.  Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution , 2012, Journal of Clinical Microbiology.

[23]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[24]  F. Dromer,et al.  Debaryomyces hansenii (Candida famata), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii (Candida guilliermondii) , 2008, Journal of Clinical Microbiology.

[25]  B. Taiwo,et al.  Candida haemulonii Complex Species , Brazil , January 2010 – March 2015 , 2019 .

[26]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[27]  Steven D. Brown,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Third informational supplement , 2008 .